This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Cancer Research Technology Limited. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Frederic Elustondo: Innovator in Cancer Research
Introduction
Frederic Elustondo is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cancer research through his innovative work. With a focus on developing compounds that inhibit specific kinase activities, Elustondo has been at the forefront of creating potential treatments for proliferative disorders.
Latest Patents
Elustondo holds 2 patents related to pyrimidinone derivatives as CDC7 inhibitors. These inventions involve compounds that function as inhibitors of the cell division cycle 7 (Cdc7) kinase enzyme activity. The patents also encompass pharmaceutical compositions that include these compounds, aimed at treating various proliferative disorders, including cancer. The implications of his work extend to other diseases or conditions where Cdc7 kinase activity plays a critical role.
Career Highlights
Frederic Elustondo is associated with Cancer Research Technology Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing battle against cancer, contributing to the understanding and treatment of this complex disease.
Collaborations
Elustondo collaborates with esteemed colleagues, including Mathew L Calder and Katherine M Fowler. Their combined expertise enhances the research efforts at Cancer Research Technology Limited, fostering innovation in cancer treatment.
Conclusion
Frederic Elustondo's contributions to cancer research through his innovative patents highlight his commitment to improving treatment options for patients. His work exemplifies the vital role of inventors in advancing medical science and addressing critical health challenges.